Michelle Ray, Director of Customer Success with Greenphire, explores the challenges that delayed payments pose to research site sustainability. Michelle highlights key issues like the burden of delayed payments on site operations and recruitment, the complexity of invoicing, and the role of technology in simplifying payment workflows. Learn how innovating payment systems can streamline financial processes, creating a more sustainable future for sites, patients, and sponsors alike.

Renuka Agarwal, CEO and co-founder of UpTrials, is revolutionizing site workforce challenges. Renuka shares the inspiration behind founding UpTrials, and how the platform is making a significant impact by matching research sites with skilled candidates. Learn how UpTrials is streamlining the hiring process, improving time-to-fill rates, and bringing much-needed innovation to clinical research hiring processes.

UpTrials is AI-driven software designed to help clinical research employers hire top talent quickly. The platform algorithmically matches employers with prescreened candidates who have clinical research experience, training, or transferable skills, covering roles from coordinators to site leadership. Employers can contact UpTrials at info@uptrials.com, and job seekers can sign up at app.uptrials.com.

Carlos Bussey, CEO of Accelerate Recruitment Services, dives deep into the groundbreaking innovations his company is bringing to the table and their role in the SCRS Global Impact Partner program. Hear the journey of this forward-thinking organization working to support clinical research sites and revolutionize patient recruitment.

In this episode of SCRS Talks, we spoke with Jane Myles, VP of Clinical Trial Innovation at Curebase, a new Global Impact Partner. Jane shares what research sites should know about decentralized trial technology and some initiatives Curebase is working on that will impact sites.

Join SCRS in welcoming Clinical ink to the Global Impact Partner (GIP) program! Syed Faridi, Senior Director of Business Development, and Lane Nichols, Executive Vice President, Head of Product, share why they decided to become a GIP and what they see for the future of their relationship with clinical research sites.

This Clinical Trials Day is especially meaningful to SCRS because it is the same day as SCRS' first-ever Diversity Site Solutions Summit.  To share a preview of some of the critical discussions that we'll cover at the Summit, we are joined by Lorena Kuri from Bristol Myers Squibb, Lloryn Hubbard from PPD, and Jaleeysa King from Greenphire. We'll highlight some of the industry's biggest wins and opportunities to improve diverse representation in trials.  Plus, they'll share how they plan to partner with sites to meet the industry's diverse enrollment goals.

Please join us in welcoming Aspen Insights to the SCRS Global Impact Partner program! Walter Storm, co-founder and CEO of Aspen Insights shares how his organization is listening to sites to understand their pain points and developing solutions to resolve them using data analytics. Listen to hear some initiatives Aspen Insights is working on to support site sustainability and streamlined trial enrollment through applied data science, artificial intelligence, and machine learning.

In this episode, SCRS is excited to showcase H1, one of SCRS' newest Global Impact Partners. We spoke with Adam Wyckoff, Director of Product Management, Clinical Trials, who shares why H1 believes listening to site voices is important and how they plan to work more closely with research sites in the future.  For more information about H1, please reach out to H1 at elizabeth.schwartz@h1.co.

SCRS is celebrating 10 years since our founder, Christine K. Pierre, officially formed the organization! We spoke with Clare Grace, Chief Patient Officer at one of SCRS' first Global Impact Partners, Parexel, to look back on why SCRS was created and how it has evolved through the years. We also explore current industry challenges SCRS is working to address, including how prioritizing site success impacts everyone in clinical research.

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act.  This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge, who shares more insight into this new law and how it may affect enrollment of diverse communities in trials.

Comprised of experienced and committed executives representing different segments of the clinical research industry, the SCRS Leadership Council provides strategic guidance, policy decisions and oversight to SCRS. Our newest Leadership Council member Mohammad A. Millwala, CEO of DM Clinical Research, shares how he initially became involved with SCRS,  industry initiatives he is excited to work on, and predictions for the future of the site community.

In this episode, we're discussing a new U.S. law condition that states Medicaid is to cover the trial-related routine care costs for Medicaid beneficiaries in clinical trials. Effective January 2022, there is a new form for principal investigators to use in these instances to secure Medicaid coverage, creating an additional and potentially burdensome step for research sites and patients with Medicaid coverage.

David Vulcano, SCRS Honorary President and Vice President of Research Compliance & Integrity at HCA Healthcare has been close to this subject and will share some insights on what types of sites this affects and advice to navigate this new challenge.

In February 2022, the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act was submitted to legislation. Kim Kundert, Sr. Vice President of Site Development Services at Total Diversity Clinical Trial Management, joins us to discuss how the industry can prepare for upcoming changes surrounding diverse patient participation in clinical research.

Learn more about the DEPICT Act: https://myscrs.org/resources/depict-act/

Be a part of these critical discussions surrounding diversity in clinical trials at the SCRS IncluDE Site Solutions Summit: sitesolutionssummit.com

Gary White, the Senior Director with EMEA Strategic Site Solutions at IQVIA explores the evolution of patient-finding technology. In this episode, discover how IQVIA's digital solutions are reshaping traditional data collection methods, unlocking new possibilities for research sites and patients. Uncover the transformative impact of digital patient-finding technology on research site operations. Join us as we discuss the challenges, benefits, and future prospects of integrating these technologies into clinical trials.

As many organizations within the clinical research industry search for candidates, many want to work with those they already know. Unfortunately, this means some CROs and sponsors are asking site staff to come and work for their organizations instead.  Karri Venn, Chief Operating Officer, President, and Chair of the Operating Board at Centricity Research discusses her experience with site staff poaching practices and how sites and industry can address the increasing demand for employees.

Collaborating with other sites can expand your site's opportunities and revenue significantly when done right. Kay Scroggins, Steve Satek, and Ana Marquez discuss why they founded their new site network, Flourish Research, and advice they have for other sites looking to expand, sell or collaborate with one another. Find out how your site can grow through partnerships in this episode.

Jackie Kent, Chief Customer Officer at Medidata, a Dassault Systèmes company, shares background on the SCRS Diversity Awareness Program and takeaways from hosting diversity-focused discussions with sites, patients, and industry partners. What strategies are working, and what can we expect next to ensure better diversity in clinical trials? Listen to this episode to learn more and be sure to join us at the inaugural Diversity Site Solutions Summit in Austin, Texas this May! https://diversitysitesolutionssummit.com/

What does receiving the SCRS Eagle Award mean for the clinical research industry and the organizations that receive it? SCRS sits down with Liz Rogers, Vice President, Head of Global Site and Study Operations at Pfizer, the 2021 Eagle Award recipient, to hear what receiving the award means to Pfizer. Rogers also shares some insight into what Pfizer will be working on over the next year and a special message for clinical research sites.

Learn more about the SCRS Global Site Solutions Summit and Eagle Awards: https://sitesolutionssummit.com/

Supporting site sustainability is the #1 priority for SCRS and its Global Impact Partners. Silvina Baudino, Director, Site Engagement, shares why Teckro recently became an SCRS Global Impact Partner, and some initiatives their organization is working on that will impact clinical research sites. Learn more about Teckro and what this new relationship means for SCRS and its site community!

Rodrigo Garcia, MD, MS, Vice President of Patient Solutions at PPD, part of Thermo Fisher Scientific, sits down with SCRS to discuss what receiving the 2021 Eagle Award means to PPD and the industry, some takeaways from the 2021 Global Site Solutions Summit, and a preview from what to expect from PPD over the next few years.

Learn more about the SCRS Eagle Awards: https://sitesolutionssummit.com/

Sandy Smith, Senior Vice President of Clinical Solutions and Strategic Partnering at WCG Clinical and SCRS Global Oncology Summit Chair shares what she is most excited about for this year's Oncology Summit, including some of the hot topics we will cover at the Summit. Learn what attendees can expect from the Summit and how to maximize your experience!

Learn more about the Global Oncology Summit and register today at https://oncologysitesolutionssummit.com/

Meet SCRS' new Honorary President, David Vulcano, as we discuss what this new role means to him and SCRS. David shares his vision for the future of our organization and the clinical research industry as we look ahead to SCRS initiatives for 2022.

Tune in as Steven Geller, PhD, Medical Director at Centennial Medical Group, shows you the patient recruitment strategy that earned the 2021 SCRS Site Patient Recruitment Innovation Award (SPRIA), which celebrates one site that has demonstrated innovation in its patient enrollment. Dr. Geller also shares insights on industry recruitment challenges and how sites can achieve and exceed enrollment goals. Learn more about SPRIA at https://sitesolutionssummit.com/

What does it mean for sites to be patient-centric? Learn from Ellen Price, Director of Patient Engagement at Meridian Clinical Research, the recipient of the 2021 Excellence in Patient Centricity Award. Ellen walks us through the programs that grew her organization despite the challenges of COVID-19 and how other sites can establish consistent patient-centric practices. Learn more about the SCRS Excellence in Patient Centricity Award at https://sitesolutionssummit.com/

Meet SCRS Global Impact Partner, Science 37! Dr. Debra Weinstein, Vice President of Internal Medicine, discusses Science 37's dedication to site success and collaboration. Hear insights into Science 37's initiatives, including their referral network and recruitment strategies, as well as their groundbreaking Metasite™ model.

The Christine K. Pierre Site Impact Award recognizes an industry leader who has made tremendous contributions to the site community through their dedication, actions and innovation. They exemplify the mission of SCRS to unify the voice of the global clinical research site community for greater site sustainability and uphold the pillars of SCRS by supporting the education, advocacy, mentorship and connection of clinical research sites. Michele Cameron, BSN, MBA, CCRC, Director of Research at Clearwater Cardiovascular Consultants, embodies the essence of this award. We sit down with Michele, this year's CKP Site Impact Award recipient, to learn about her site, how she has grown that organization to what it is today, and how winning this award has impacted her and her site. 

We sit down with Stacey Bledsoe, the Advisor for Clinical Trial Diversity at Eli Lilly and Company (Lilly) to talk about what is being done in the industry to advance diversity in clinical trials. Stacey touches specifically on some of the work Lilly is doing, as well as diving specifically into the Oncology therapeutic area. The needs of this community are different, yet just as important as others yet at times does not get the attention it needs. Stacey gives us lessons that we can apply to our trials at both the Sponsor and CRO level, as well as the site community. 

Kay Scroggins, President and CEO of Clinical Trials of Texas and the SCRS 2021 Global Site Solutions Summit chair shares what she is most excited about for this year’s Global Summit in Hollywood, Florida. Tune in as we discuss can’t-miss sessions and how attendees can maximize their experience at the Summit.

The importance of diversity in clinical research has been a hot topic in the industry for many years. Led by Diana Foster, SCRS’ Vice President of Special Projects and Strategy, SCRS established its Diversity Awareness Program in 2016 and has developed several tools to further this important industry initiative. In this episode, Foster also discusses the program's newest accomplishment, the Diversity Site Assessment Tool (DSAT) – an assessment that provides guidance for clinical research sites to improve their ability to recruit diverse patient populations in trials.

Learn more about the program at https://myscrs.org/learning-campus/diversity-in-clinical-trial

Each year at the Global Site Solutions Summit, SCRS selects the Site Patient Recruitment Innovation Award (SPRIA) and Site Tank award winners. Hear from last year's recipients, Clinical Trials of Texas and Accelerated Enrollment Solutions (AES), respectively, as they reflect on what receiving these awards has done for their site, how they have tackled the challenges 2020 presented, and what they are doing as they look to the future.

For more information on SPRIA, Click Here
For more information on Site Tank, Click Here.

SCRS has an exciting Asia-Pacific Site Solutions Summit planned for July 13-14, 2021! Although we cannot be together in person down in Melbourne, Australia, our virtual experience will provide two days full of interactive and informative sessions. Tam C. Nguyen, FRSPH, FAIM, F. AustRMS, PhD, MBA, and Summit Chair for the 2021 SCRS Asia-Pac Site Solutions Summit, shares why you should consider joining us for the virtual Summit, how to maximize your experience, and some of the engaging and industry-leading session topics we have planned for attendees this year.

Clinical Trials Day is a special occasion for SCRS. This year, we took time to reflect on what being part of this important work means to us and the tremendous challenge that our industry overcame in 2020 and early 2021. When we stopped to think of truly inspiring and innovative progress that was made in spite of these challenges Pfizer was the first organization that came to mind. We had the opportunity to speak with Liz Rogers, Vice President and Head of Global Site and Study Operations and Sarah Tweedy, Vice President and Head of Vaccine Clinical Operations at Pfizer about what they think the future of research is and how their organization adapted and quickly became a household name in COVID-19 vaccine development. 

The 2021 European Site Solutions Summit is upon us! SCRS has some world-class content planned for this year’s summit, being held as a virtual experience April 20, 21, and 22nd. We sat down with Vivienne van de Walle, the European Site Solutions Summit program chair and the Owner and Medical Director at PT&R, a site in the Netherlands to learn about what this upcoming summit has to offer attendees and why she is excited for this year’s summit.

The 2021 Global Oncology Site Solutions Summit, Virtual Experience will be one to remember. Although we can't be together in person this year, SCRS is showcasing some great content this year that will help the Oncology community take their work to the next level. Hear from the SCRS Oncology program chair, Archana Sah as she teases some of the great content taking place at this year's Oncology Summit.

"Innovation" is a term often used to describe many things, particularly in the clinical research space. Our industry's need for meaningful innovation has never been more apparent than it is right now. We sit down with Craig Lipset, the Managing Partner of Clinical Innovation Partners and Assistant Professor of Health Informatics at Rutgers University to discuss what innovation looks like and how this has changed as a result of our pandemic. As A teaser to his keynote presentation at the 2020 Global Site Solutions Summit, Craig will also highlight some of the key points he will address at his talk. 

Jillian Agnew, Senior Clinical Research Nurse at St. Johns Center for Clinical Research, shares insights on the power of personal connections in keeping trial participants engaged. From navigating trial fatigue to overcoming protocol challenges, hear the nuances of patient interactions that shape the success of long-term trials. Tune in to learn how to foster meaningful connections to create lasting participant retention and engagement.

Understanding the nuances and proper tactics for negotiating a budget with a clinical research trial pharmaceutical sponsor could be considered an art to some. We sit down with Dawn Pittinger at BioOptronics to discuss and learn where the current state of negotiating with a sponsor is in today's rapidly changing world, as well as tactics that can be employed to help assure success at the research site level. 

Recruiting clinical research patients is often times a tremendous challenge for a site. In the era of COVID-19, this problem has only grown more difficult to manage. Matt Miller, President of StudyKik discusses what these challenges are and how they are different in our current environment as well as ways to overcome those unique challenges. It is critically important to understand how recruitment is changing and what can be done to meet this situation head-on. Finding patients and assuring their safety and making the experience as convenience as possible is of utmost importance and Matt discusses how we can address this. 

For years, sites have been talking about and navigating through traditional remote site monitoring, where a Clinical Research Associate (CRA) from a Sponsor or CRO performs monitoring activities remotely, over the phone and via email to reduce trips to the site. However, in the age of decentralized trials companies have pioneered a new ways to effectively monitor sites remotely. In comes VirtualPreSite and their glasses technology, allowing remote views into the sites. We sit down with Deric Frost, VirtualPreSite's Head of Virtual Site Monitoring to discuss how this technology is changing the way trials are monitored. 

As many in the clinical research industry adopt work-from-home policies in response to the COVID-19 pandemic, it is a critical time to consider the cyber security of your work. There are people out there looking for opportunities to take advantage of the situation and are attempting to hack our computers and access business data. It is important that businesses consider cyber insurance as added protection. Hear from our partners at Hylant as they discuss what this means for you and the best steps your business can take. 

In terms of the service the site provides to the sponsor of a study, regulatory work is of utmost importance -- and many times a defining factor of service quality overall. Especially in the time of COVID, regulatory teams are burdened with figuring out how to make sure this critical work is done and done well even when everyone involved is not in the same room. But, many regulatory teams have figured out that there are issues beyond simply where people are working that are plaguing the quality of this work. So how do regulatory teams provide the highest quality especially during this time? We decided to ask an expert - Rick Arlow, founder of Complion.

Oncology trials present a unique challenge in the clinical research space, particularly when it comes to patient recruitment. The identification windows are narrow, yet participation in precision trials can have life saving options for many patients with an unfortunate diagnosis. The CEO and Co-Founder of Deep Lens, Dave Billiter talks with us about how this recruitment is such a challenge and what tools may be available to help this process as well as how communication is key to running a successful recruitment campaign. 

Decentralized clinical trials in a post COVID-19 world are undoubtedly here to stay. Recent events have had a drastic effect that is likely lasting as it relates to trials at the site levels. This can be a positive thing. Much of what sites can do now is prepare for this new future and VirTrial's Senior Vice President of Business Development, Amanda Rangel talks with us about just that. There is much to do, and now is the time to do it so that you are ready for what is coming and the future of clinical trials. 

Budgets for clinical trials are always a highly discussed topic and one that SCRS regularly addresses with our partners on behalf of sites. Catherine Click, Greenphire's director of clinical pricing and analysis talks with us about how sites can "get their ducks in a row" to better negotiate and justify their study budgets. Not only can sites be more effective in their negotiations, but we also discuss some ways to better speed the time it takes to negotiate that budget. Having the data and information to back your fees is a critical component of which this interview discusses. 

IQVIA Technologies is focused on using innovation to enable better relationships with sites. Part of this strategy is centered around remote data monitoring strategies to address reducing staffing and CRA mobility. MaryAnne Rizk, PhD with IQVIA Technologies discusses how these technologies ensure patient and staff safety amidst the current pandemic, as well as how we can all work better to keep current clinical trials on track. We also look to the future and how artificial intelligence and machine learning can begin to see their day at sites. 

Amidst these interesting times in the age of COVID-19, we know that this has already affected sites, CRO's and Sponsors.  It's not over yet and we don’t know the long-term impact from the disruption. What we do know is that all stakeholders are repositioning, trial continuity is front and center, and sites are focused on site and study sustainability through retention efforts and are quickly adopting decentralized methods. Circuit Clinical's CEO Irfan Khan sits down to discuss what patient engagement of the future will look like and how can engagement be applied to the site of tomorrow. 
 

Joseph Kim, Chief Strategy Officer at ProofPilot, shares the challenges and triumphs of implementing innovation in the clinical research field. Joseph highlights lessons learned and insights from ProofPilot's Innovation Playbook on the importance of problem-solving and collaborative value creation. Discover practical tips for finding funds, navigating tight timelines, and bringing innovation to life! 

COVID-19 has highlighted a need for patients, sites, and sponsors to work together more effectively and remotely. Yet, efforts to do so are often limited by systems and processes that limit data sharing and collaboration. We’re sitting down with Bree Burks from Veeva Systems to discuss new opportunities to address this challenge by making it easier for study partners to work together across the full clinical trial life cycle. From their unique prospective, we explore some of the unique challenges the industry is facing and where there are opportunities for the future. 

We sat down with Lauren Litzinger at Pfizer to discuss virtual monitoring of clinical research sites and studies. We are seeing a shift in how monitoring is being conducted in the wake of COVID-19 and the requirement for so many activities to go virtual and digital. Monitoring is no exception. Various options for data verification and review are discussed, as well as what are some of the changes being seen at the pharmaceutical sponsor level. 

IQVIA Technologies has focused on three important areas for deploying technology to support sites. Melissa Easy from IQVIA discusses with us how technology is affecting sites, sponsors, and CROs and how their approach to technology is changing the relationship. The focus has to be on how technology can make the lives of sites easier, and addressing the concerns sites have specifically around payments and finances. Having one place to direct sites in order to help navigate virtual challenges and technology is one such specific solution proposed by IQVIA.